APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 76 filers reported holding APYX MEDICAL CORPORATION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,472,669 | +45.2% | 460,209 | +128.3% | 0.00% | – |
| Q2 2023 | $1,013,907 | +338999.3% | 201,572 | +94.3% | 0.00% | – |
| Q1 2023 | $299 | -11.0% | 103,755 | -27.8% | 0.00% | – |
| Q4 2022 | $336 | -100.0% | 143,774 | -27.3% | 0.00% | -100.0% |
| Q3 2022 | $888,000 | -58.7% | 197,785 | -46.1% | 0.00% | 0.0% |
| Q2 2022 | $2,148,000 | +185.3% | 366,627 | +217.8% | 0.00% | – |
| Q1 2022 | $753,000 | +8.2% | 115,362 | +112.5% | 0.00% | – |
| Q4 2021 | $696,000 | +30.3% | 54,287 | +40.9% | 0.00% | – |
| Q3 2021 | $534,000 | -62.4% | 38,532 | -72.1% | 0.00% | -100.0% |
| Q2 2021 | $1,422,000 | +668.6% | 137,963 | +619.4% | 0.00% | – |
| Q1 2021 | $185,000 | -29.1% | 19,178 | -47.2% | 0.00% | – |
| Q4 2020 | $261,000 | +128.9% | 36,304 | +50.6% | 0.00% | – |
| Q3 2020 | $114,000 | -96.2% | 24,110 | -95.0% | 0.00% | -100.0% |
| Q1 2019 | $3,031,000 | – | 480,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Archon Capital Management LLC | 2,449,402 | $23,661,000 | 3.40% |
| Taylor Frigon Capital Management LLC | 611,712 | $5,909,000 | 1.82% |
| Roubaix Capital, LLC | 180,874 | $1,747,000 | 1.18% |
| Millrace Asset Group, Inc. | 176,587 | $1,706,000 | 0.92% |
| Cowen Prime Services LLC | 248,959 | $2,405,000 | 0.91% |
| RTW INVESTMENTS, LP | 3,391,279 | $32,760,000 | 0.51% |
| Lighthouse Financial Advisors, Inc. | 162,598 | $1,570,000 | 0.48% |
| COWEN AND COMPANY, LLC | 522,042 | $5,043,000 | 0.35% |
| WOLFF WIESE MAGANA LLC | 37,017 | $358,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 958,488 | $9,259,000 | 0.26% |